Success Metrics

Clinical Success Rate
100.0%

Based on 8 completed trials

Completion Rate
100%(8/8)
Active Trials
2(18%)
Results Posted
50%(4 trials)

Phase Distribution

Ph not_applicable
1
9%
Ph phase_2
3
27%
Ph phase_3
1
9%
Ph phase_4
5
45%

Phase Distribution

0

Early Stage

3

Mid Stage

6

Late Stage

Phase Distribution10 total trials
Phase 2Efficacy & side effects
3(30.0%)
Phase 3Large-scale testing
1(10.0%)
Phase 4Post-market surveillance
5(50.0%)
N/ANon-phased studies
1(10.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

8 of 8 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(8)
Other(1)

Detailed Status

Completed8
Recruiting2
unknown1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 23 (30.0%)
Phase 31 (10.0%)
Phase 45 (50.0%)
N/A1 (10.0%)

Trials by Status

unknown19%
recruiting218%
completed873%

Recent Activity

2 active trials
Showing 5 of 11
recruitingnot_applicable

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

NCT06984822
completedphase_4

Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

NCT04411693
recruiting

OCT and OCT-Angiography Biomarkers of Treatment Response to Dexamethasone Implant in Macular Edema Due to Retinal Vascular Diseases - DME and RVO

NCT06332690
unknownphase_4

Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema

NCT04448496
completedphase_4

Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema

NCT04089605
View all 11 trials

Clinical Trials (11)

Showing 11 of 11 trials
NCT06984822Not Applicable

Evaluation of Serum- and OCT Biomarkers in Patients With DME Treated With Anti-VEGF or Dexamethasone Implant

Recruiting
NCT04411693Phase 4

Comparative Study of Dexamethasone Implant to Intravitreal Aflibercept in Subjects With Diabetic Macular Edema

Completed
NCT06332690

OCT and OCT-Angiography Biomarkers of Treatment Response to Dexamethasone Implant in Macular Edema Due to Retinal Vascular Diseases - DME and RVO

Recruiting
NCT04448496Phase 4

Prospective Trial of Dexamethasone implAnt for Treatment Naïve diabeTic Macular Edema

Unknown
NCT04089605Phase 4

Ranibizumab vs Dexamethasone Implant in Vitrectomized Eyes With Diabetic Macular Edema

Completed
NCT01903720Phase 4

A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion

Completed
NCT01951066Phase 2

Diabetic Macular Edema Treated With Ozurdex (DMEO)

Completed
NCT01790685Phase 2

Ozurdex for Retinal Vein Occlusion Study (ORVO Study)

Completed
NCT01396057Phase 3

Efficacy and Safety of Ranibizumab Intravitreal Injections Versus Dexamethasone Intravitreal Implant in Patients With Branch Retinal Vein Occlusion (BRVO)

Completed
NCT01767545Phase 4

Dexamethasone-implant for the Treatment of RVO

Completed
NCT01284478Phase 2

Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery

Completed

All 11 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
11